HAVAH Therapeutics logo

HAVAH Therapeutics

Developing prevention and early treatment options for hormonally driven breast cancer and other breast diseases.

5 employees · est. 2005 · Australia

VS
Hera-MI logo

Hera-MI

Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection

22 employees · est. 2017 · Saint-herblain, France

HAVAH Therapeutics is the older company (2005 vs 2017); Hera-MI is the larger of the two.

Side-by-Side Comparison

HAVAH Therapeutics Hera-MI
Founded
2005 older 2017
Headquarters
Australia Saint-herblain, France
Employees
5 22 larger
Industry
Biotechnology, Health Care, Pharmaceutical AI, Biotechnology, Health Care
Funding Stage
Series Unknown Non Equity Assistance
Total Funding
$1.51M Not tracked yet
Funding Rounds
2 1
Services
Not tracked yet Development of AI-powered software solutions for breast cancer diagnosis and mammography analysis
Target Customers
Not tracked yet Radiologists, senologists, healthcare institutions
Taxonomy
Breast Cancer Prevention, Hormonal Therapy, Breast Cancer Treatment, Metastatic Cancer, Clinical-stage Pharmaceutical Company, Endocrine Therapy, Hormonal Regulation, Autoimmune Breast Diseases, ER+ Breast Cancer, Hormonal Resistance, Clinical Experience, Prevention Therapies, Quality Of Life Improvement, Women's Health, Cancer Prevention Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, CAD, Digital Medical Imaging, Early-stage Diagnosis, Healthcare Innovation
Website
havahtx.com hera-mi.com
HAVAH Therapeutics logo

About HAVAH Therapeutics

Name: HavaH Therapeutics Slogan: Developing prevention and early treatment options for hormonally driven breast cancer and other breast diseases. Description: HavaH’s mission is to develop therapies with reduced side effects and early prevention of breast cancers including hormonal refractory ER+ b...

Hera-MI logo

About Hera-MI

Hera-MI is a startup based in France founded in 2017 with a mission to shape the future of radiology by utilizing AI and radiologists to enhance early detection of breast cancer. The company is focused on leveraging AI to increase the recovery rate and optimize healthcare treatment for women. Hera-M...

We will tell you when either one moves

BounceWatch watches HAVAH Therapeutics and Hera-MI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at HAVAH Therapeutics and Hera-MI — by email.

Frequently Asked Questions

HAVAH Therapeutics — Developing prevention and early treatment options for hormonally driven breast cancer and other breast diseases.. Hera-MI — Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
HAVAH Therapeutics has raised $1.51M while Hera-MI has raised undisclosed funding.
HAVAH Therapeutics and Hera-MI operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare HAVAH Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at HAVAH Therapeutics on 12 Sep 2024, and Hera-MI on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes